Effect of autologous hematopoietic stem cell transplantation on multiple sclerosis and neuromyelitis optica spectrum disorder: a PRISMA-compliant meta-analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of autologous hematopoietic stem cell transplantation on multiple sclerosis and neuromyelitis optica spectrum disorder: a PRISMA-compliant meta-analysis
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-05
DOI
10.1038/s41409-020-0810-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation
- (2019) Andreas Tolf et al. ACTA NEUROLOGICA SCANDINAVICA
- Nine-year follow up after hematopoietic stem cell transplantation in five multiple sclerosis patients
- (2019) Elizabeth R. Comini-Frota et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Self‐reported changes in the expanded disability status scale score in patients with multiple sclerosis after autologous stem cell transplants: real‐world data from a single center
- (2019) G. J. Ruiz‐Argüelles et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica
- (2019) Richard K. Burt et al. NEUROLOGY
- Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis
- (2018) John J Moore et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Efficacy and safety of autologous hematopoietic stem-cell transplantation in multiple sclerosis: a systematic review and meta-analysis
- (2018) Fangfang Ge et al. NEUROLOGICAL SCIENCES
- Long-term follow-up more than 10 years after HSCT: a monocentric experience
- (2017) Jessica Frau et al. JOURNAL OF NEUROLOGY
- Autologous haematopoietic stem cell transplantation for neurological diseases
- (2017) Joachim Burman et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
- (2017) Paolo A. Muraro et al. Nature Reviews Neurology
- Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
- (2017) Bonaventura Casanova et al. NEUROLOGICAL SCIENCES
- High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS
- (2017) Richard A. Nash et al. NEUROLOGY
- Multiple sclerosis - etiology and diagnostic potential
- (2017) Joanna Kamińska et al. Postepy Higieny I Medycyny Doswiadczalnej
- Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
- (2017) Paolo A. Muraro et al. JAMA Neurology
- Haemopoietic stem-cell transplantation for multiple sclerosis: what next?
- (2016) Jan Dörr LANCET
- Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial
- (2016) Harold L Atkins et al. LANCET
- Epidemiology of Multiple Sclerosis
- (2016) Jonathan Howard et al. NEUROLOGIC CLINICS
- Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician’s and patient’s perspectives
- (2015) Jury L. Shevchenko et al. ANNALS OF HEMATOLOGY
- Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis
- (2015) Richard K. Burt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
- (2014) Joachim Burman et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party
- (2014) Raffaella Greco et al. Multiple Sclerosis Journal
- Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis
- (2012) Jury L. Shevchenko et al. EXPERIMENTAL HEMATOLOGY
- Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results
- (2011) J D Bowen et al. BONE MARROW TRANSPLANTATION
- Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience
- (2011) GL Mancardi et al. Multiple Sclerosis Journal
- Long-term efficacy of autologous haematopoietic stem cell transplantation in multiple sclerosis at a single institution in China
- (2011) Bing Chen et al. NEUROLOGICAL SCIENCES
- Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population
- (2010) Juan Xu et al. ANNALS OF HEMATOLOGY
- High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience
- (2010) Eva Krasulová et al. Multiple Sclerosis Journal
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
- Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG
- (2009) N Hamerschlak et al. BONE MARROW TRANSPLANTATION
- Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases
- (2009) D. Farge et al. HAEMATOLOGICA
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More